Re-evaluating the role of dacarbazine in metastatic melanoma: What have we learned in 30 years?

Keyphrases

• Metastatic Melanoma 100%
• Dacarbazine 100%
• Immunotherapeutics 14%
• Refractory Disease 14%
• Clinical Outcomes 14%
• Total Dose 14%
• Effective Therapy 14%
• Antiemetics 14%
• Dosing Schedule 14%
• Treatment Refractory 14%
• Multiple Dose 14%
• Clinically Meaningful Improvement 14%
• Agent Behavior 14%
• Advanced Melanoma 14%
• Single Administration 14%
• Patient Comfort 14%
• Utilization Time 14%
• Evidence-based Review 14%
• Clinic Utilization 14%

Medicine and Dentistry

• Metastatic Melanoma 100%
• Dacarbazine 100%
• Single Drug Dose 28%
• Disease 14%
• Antiemetic 14%
• Infusion 14%
• Drug Dose Regimen 14%
• Multiple Drug Dose 14%
• Patient Comfort 14%
• Melanoma 14%